Hiromi Kataoka Selected Research

Stomach Neoplasms (Stomach Cancer)

12/2022	Phase II Prospective Study of Trastuzumab in Combination with S-1 and Oxaliplatin (SOX100) Therapy for HER2-Positive Advanced Gastric Cancer.
1/2021	Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer.
11/2020	Novel urinary protein biomarker panel for early diagnosis of gastric cancer.
12/2019	A novel urinary microRNA biomarker panel for detecting gastric cancer.
1/2019	Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer.
4/2017	Urinary kallikrein 10 predicts the incurability of gastric cancer.
11/2016	Anticancer Effects of a New Aminosugar-conjugated Platinum Complex Agent Against Cisplatin-resistant Gastric Cancer.
1/2016	A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer.
3/2015	Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats.
1/2015	Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiromi Kataoka Research Topics

Disease

53	Neoplasms (Cancer) 04/2022 - 03/2005
31	Stomach Neoplasms (Stomach Cancer) 12/2022 - 01/2004
12	Ulcerative Colitis 11/2021 - 12/2009
10	Crohn Disease (Crohn's Disease) 01/2019 - 01/2012
9	Colonic Neoplasms (Colon Cancer) 02/2022 - 03/2005
8	Adenocarcinoma 02/2022 - 09/2017
8	Carcinoma (Carcinomatosis) 03/2021 - 03/2005
6	Hemorrhage 03/2022 - 12/2009
6	Inflammation (Inflammations) 08/2015 - 04/2005
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2011
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2009
5	Ulcer 04/2019 - 10/2007
5	Infections 06/2018 - 09/2005
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2015 - 02/2010
4	Gastric Outlet Obstruction 10/2021 - 08/2009
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 11/2011
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 07/2009
3	Adenoma (Adenomas) 02/2022 - 09/2017
3	Necrosis 03/2021 - 07/2016
3	Chronic Pancreatitis 02/2021 - 04/2005
3	Ascites 02/2021 - 01/2017
3	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 03/2017
3	Gastroesophageal Reflux (GERD) 04/2019 - 01/2011
3	Diarrhea 01/2014 - 12/2009
3	Neoplasm Metastasis (Metastasis) 08/2010 - 08/2008
2	Hepatitis B 01/2022 - 01/2022
2	Body Weight (Weight, Body) 01/2022 - 02/2010
2	Chronic Renal Insufficiency 11/2021 - 01/2020
2	Carcinogenesis 07/2021 - 03/2015
2	Pain (Aches) 07/2021 - 06/2018
2	Pathologic Constriction (Stenosis) 02/2021 - 01/2021
2	Congenital Abnormalities (Deformity) 03/2020 - 04/2011
2	Anemia 01/2020 - 10/2007
2	Polyps 04/2019 - 09/2017
2	Acute Kidney Injury (Acute Renal Failure) 04/2018 - 04/2016

Drug/Important Bio-Agent (IBA)

18	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2022 - 03/2011
15	Photosensitizing Agents (Photosensitizers)IBA 04/2022 - 03/2011
13	Adalimumab (Humira)FDA Link 01/2019 - 01/2012
11	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 03/2011
10	chlorinIBA 02/2021 - 03/2011
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2017
9	Talaporfin (talaporfin sodium)IBA 02/2021 - 03/2011
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2019 - 02/2010
7	Epidermal Growth Factor (EGF)IBA 01/2013 - 03/2005
6	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 06/2009
6	ErbB Receptors (EGF Receptor)IBA 12/2022 - 06/2008
6	phytochlorinIBA 04/2022 - 01/2018
6	Pharmaceutical PreparationsIBA 11/2021 - 03/2009
6	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 03/2011
5	Mannose (D-Mannose)IBA 04/2022 - 04/2017
5	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2019
5	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 08/2008
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2005
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2005
5	Tacrolimus (Prograf)FDA LinkGeneric 06/2019 - 04/2005
5	Proton Pump InhibitorsIBA 04/2019 - 01/2011
5	Infliximab (Remicade)FDA Link 01/2019 - 09/2012
5	LigandsIBA 01/2015 - 08/2004
5	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2013 - 06/2008
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2022 - 03/2011
4	Biological ProductsIBA 02/2021 - 01/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2009
4	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2015 - 12/2009
3	Trastuzumab (Herceptin)FDA Link 12/2022 - 01/2015
3	AntigensIBA 01/2022 - 08/2003
3	Oxygen (Dioxygen)IBA 03/2021 - 07/2016
3	SugarsIBA 02/2021 - 04/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2009
3	Antineoplastic Agents (Antineoplastics)IBA 10/2020 - 10/2011
3	Therapeutic UsesIBA 09/2018 - 01/2014
3	rebamipideIBA 03/2015 - 12/2009
3	Interleukin-8 (Interleukin 8)IBA 01/2010 - 08/2004
2	Mannose ReceptorIBA 04/2022 - 04/2017
2	Gemcitabine FDA Link 01/2022 - 06/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 10/2011
2	InterferonsIBA 01/2022 - 04/2005
2	taxaneIBA 01/2022 - 01/2012
2	Leucovorin (Folinic Acid)FDA Link 01/2022 - 03/2011
2	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2010
2	Ustekinumab (CNTO 1275)FDA Link 11/2021 - 06/2018
2	EnzymesIBA 02/2021 - 01/2009
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 01/2012
2	AcidsIBA 01/2021 - 01/2011
2	CytokinesIBA 01/2020 - 08/2004
2	Messenger RNA (mRNA)IBA 01/2020 - 04/2005
2	Rabeprazole (Aciphex)FDA Link 04/2019 - 03/2017
2	C-Reactive ProteinIBA 01/2019 - 02/2012
2	CreatinineIBA 04/2018 - 02/2017
2	SteroidsIBA 08/2017 - 06/2012

Therapy/Procedure

44	Therapeutics 12/2022 - 01/2004
17	Drug Therapy (Chemotherapy) 01/2021 - 08/2008
16	Photochemotherapy (Photodynamic Therapy) 04/2022 - 03/2011
8	Blood Component Removal (Apheresis) 11/2021 - 04/2011
6	Lasers (Laser) 04/2022 - 07/2010
5	Self Expandable Metallic Stents 01/2022 - 08/2009
5	Stents 10/2021 - 08/2009
3	Remission Induction 06/2019 - 08/2017
3	Gastrectomy 05/2012 - 10/2009
2	Chemoprevention 07/2021 - 03/2015
2	Radiotherapy 03/2017 - 06/2012